Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had revenue of 189.14M SEK in the quarter ending September 30, 2025, a decrease of -4.71%. This brings the company's revenue in the last twelve months to 813.59M, up 8.39% year-over-year. In the year 2024, Xvivo Perfusion AB had annual revenue of 822.42M with 37.63% growth.

• Revenue (ttm): 813.59M SEK
• Revenue Growth: +8.39%
• P/S Ratio: 6.41
• Revenue / Employee: 4.28M SEK
• Employees: 190
• Market Cap: 471.63M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%
Dec 31, 2020	179.86M	-40.98M	-18.55%